Brazil Moves to Break Merck’s Patent AIDS Drug Use (Update1) (Bloomberg.com)

Brazil Moves to Break Merck’s Patent AIDS Drug Use (Update1) (Bloomberg.com)
April 25 (Bloomberg) — Brazil may break the patent on Merck & Co. AIDS drug Efavirenz unless the company agrees to slash its prices within the next seven days, Health Minister Jose Gomes Temporao said.